Loading
A phase 1 trial of NST-628 run by Nader Sanai, not yet recruiting.
A Study of NST-628 in Recurrent Grade 4 Glioma is a phase 1 interventional study registered as NCT07784985 by Nader Sanai, with 12 participants planned, started 2026-10. Conditions recorded: Glioma, Recurrent High Grade and Grade 4 Malignant Glioma. Interventions recorded: NST-628.
Shares NST-628, Nested Therapeutics, Brain and spinal cord tumours (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/